We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Top Sells

Rank Stock Value
1
MDP
Meredith Corporation
MDP
+$2.9M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.77M
3
CLFD icon
Clearfield
CLFD
+$2.59M
4
QCOM icon
Qualcomm
QCOM
+$2.5M
5
TRTN
Triton International Limited
TRTN
+$2.42M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CODX
276
Co-Diagnostics
CODX
$5.64M
$321K 0.07%
1,200
– –
PCRX icon
277
Pacira BioSciences
PCRX
$1B
$313K 0.07%
5,200
-1,000
-16% -$55.1K
PRDO icon
278
Perdoceo Education
PRDO
$2.16B
$306K 0.07%
26,000
-10,000
-28% -$109K
PPL
279
PPL Corp
PPL
$26.7B
$301K 0.07%
10,000
– –
FOSL icon
280
Fossil Group
FOSL
$330M
$296K 0.07%
28,800
– –
RYAM icon
281
Rayonier Advanced Materials
RYAM
$621M
$294K 0.06%
51,500
– –
NWE icon
282
NorthWestern Energy
NWE
$4.47B
$286K 0.06%
5,000
– –
ORGO icon
283
Organogenesis Holdings
ORGO
$219M
$286K 0.06%
31,000
– –
EDIT icon
284
Editas Medicine
EDIT
$448M
$276K 0.06%
10,400
-8,200
-44% -$282K
AAPL icon
285
Apple
AAPL
$4.56T
$275K 0.06%
1,550
– –
GAP
286
The Gap Inc
GAP
$7.39B
$274K 0.06%
15,500
– –
POR icon
287
Portland General Electric
POR
$5.8B
$265K 0.06%
5,000
– –
CASA
288
DELISTED
Casa Systems, Inc. Common Stock
CASA
$265K 0.06%
46,800
-18,000
-28% -$104K
CHRS icon
289
Coherus Oncology
CHRS
$210M
$249K 0.05%
15,600
-20,400
-57% -$357K
VCEL icon
290
Vericel Corp
VCEL
$2.29B
$244K 0.05%
6,200
– –
AES icon
291
AES
AES
$10.5B
$243K 0.05%
10,000
– –
VIA
292
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$229K 0.05%
4,000
– –
ETR icon
293
Entergy
ETR
$50.4B
$225K 0.05%
4,000
– –
DUK icon
294
Duke Energy
DUK
$97.6B
$210K 0.05%
2,000
– –
HE icon
295
Hawaiian Electric Industries
HE
$2.17B
$207K 0.05%
5,000
– –
OIG
296
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$204K 0.04%
2,325
– –
ALE
297
DELISTED
Allete
ALE
$199K 0.04%
3,000
– –
NAGE
298
Niagen Bioscience
NAGE
$237M
$194K 0.04%
+52,000
New +$281K
PINS icon
299
Pinterest
PINS
$13.2B
$189K 0.04%
5,200
-4,100
-44% -$182K
AUD
300
DELISTED
Audacy, Inc.
AUD
$159K 0.03%
62,000
– –
10 11
12
13 14

Similar funds

FGP
Foyston, Gordon, & Payne Toronto, Ontario, Canada $434M AUM 9.09% 1-Year Est. Return
HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.